powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1629462676
Ruben Mylvaganam
M.D.
Pulmonary Disease
Chicago,
IL
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
QUALITY · MIPS · 2024
Final MIPS score
95.2
Quality
83.0
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.85%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$4K
Payment records
24
By payment type
Consulting Fee
$3K
Food and Beverage
$858
Education
$18
Top paying entities
Consulting Fee
$3K
Food and Beverage
$858
Education
$18
PRESCRIBING · PART D · 2024
Total Rx claims
816
Beneficiaries
—
Total drug cost
$6.9M
Distinct drugs
14
Brand share
68.1%
Top prescribed drugs
Sildenafil Citrate
129 claims
Riociguat
122 claims
Macitentan
113 claims
Treprostinil
106 claims
Treprostinil Diolamine
102 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
662
Unique beneficiaries
—
Total services
1,099
Distinct HCPCS
18
Medicare payment
$100K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 434 Pulmonary Disease providers in IL — above median (cohort median 957).
